C. Orrenius

发表

The Candida antarctica lipase B catalysed kinetic resolution of seudenol in non-aqueous media of controlled water activity

K. Hult, G. Carrea, T. Norin, 1995 .

Molecular recognition of sec-alcohol enantiomers by Candida antarctica lipase B

K. Hult, T. Norin, D. Rotticci, 1998 .

Enantiomerically enriched bifunctional sec-alcohols prepared by Candida antarctica lipase B catalysis. Evidence of non-steric interactions

K. Hult, T. Norin, D. Rotticci, 1997 .

Candida antarctica lipase B catalysed kinetic resolutions: Substrate structure requirements for the preparation of enantiomerically enriched secondary alcanols

K. Hult, T. Norin, D. Rotticci, 1995 .

Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat.

Li Xing, Patrizia Crivori, Alan G. E. Wilson, 2004, Journal of medicinal chemistry.

Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.

A. Isacchi, E. Casale, T. O'Brien, 2013, Journal of medicinal chemistry.

Preparation of 1-pyridinylethanols of high enantiomeric purity by lipase catalysed transesterifications

K. Hult, T. Norin, C. Orrenius, 1994 .

CHIRAL RECOGNITION OF ALCOHOL ENANTIOMERS IN ACYL TRANSFER REACTIONS CATALYSED BY CANDIDA ANTARCTICA LIPASE B

K. Hult, T. Norin, D. Rotticci, 1998 .

Kinetic resolutions of amine and thiol analogues of secondary alcohols catalyzed by the Candida antarctica lipase B

Anders Mattson, Karl Hult, K. Hult, 1996 .

Preparation of a Novel Cross-Linked Polymer for Second-Order Nonlinear Optics

Anders Hult, David S. Hermann, Per Rudquist, 1996 .

Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.

A. Isacchi, G. Canevari, E. Felder, 2016, Journal of medicinal chemistry.

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.

A. Isacchi, E. Casale, Daniel J. Anderson, 2013, Nature chemical biology.

Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.

E. Casale, E. Felder, A. Galvani, 2013, Bioorganic & medicinal chemistry.

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury

R. Bosotti, A. Isacchi, A. Montagnoli, 2017, Molecular Cancer Therapeutics.

Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as PIM kinase inhibitors inspired from marine alkaloids.

A. Isacchi, E. Casale, E. Felder, 2022, Chirality.

Model based on GRID-derived descriptors for estimating CYP3A4 enzyme stability of potential drug candidates

Ismael Zamora, Patrizia Crivori, Italo Poggesi, 2004, J. Comput. Aided Mol. Des..

The generation of purinome-targeted libraries as a means to diversify ATP-mimetic chemical classes for lead finding

A. Isacchi, E. Felder, S. Mantegani, 2012, Molecular Diversity.

Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.

A. Isacchi, G. Canevari, E. Felder, 2019, Journal of medicinal chemistry.